Dr. Agarwal's Health Care Limited (NSE:AGARWALEYE)

Market Cap	127.16B
Revenue (ttm)	16.00B
Net Income (ttm)	896.41M
Shares Out	315.88M
EPS (ttm)	3.09
PE Ratio	130.46
Forward PE	110.14
Dividend	n/a
Ex-Dividend Date	n/a

Volume	161,503
Average Volume	334,699
Open	401.95
Previous Close	399.75
Day's Range	394.55 - 405.10
52-Week Range	361.10 - 464.00
Beta	n/a
RSI	40.09
Earnings Date	Aug 8, 2025

About Dr. Agarwal's Health Care

Dr. Agarwal’s Health Care Limited operates eye hospitals in India and internationally. It offers cataract surgeries, such as small incision cataract surgery, phacoemulsification, robotic cataract surgery, and glued intraocular lens treatments; and refractive surgeries, including surgical procedures to correct the refractive error of the eye to get rid of or reduce dependence on glasses and contact lens. The company also provides surgical retinal treatments, corneal transplantation and pinhole pupilloplasty, oculoplasty, and surgeries for the tr...

• Industry: Medical Instruments & Supplies
• Sector: Healthcare
• Founded: 2010
• Employees: 4,214
• Stock Exchange: National Stock Exchange of India
• Ticker Symbol: AGARWALEYE

Financial Performance

In 2023, Dr. Agarwal's Health Care's revenue was 13.32 billion, an increase of 30.86% compared to the previous year's 10.18 billion. Earnings were 830.61 million, a decrease of -11.73%.